Page 374 - 2021 IDMT Digital
P. 374
LYME DISEASE
Introduction:
• 0RVW FRPPRQ WLFN ERUQH GLVHDVH LQ WKH 86 DQG (XURSH
• &DXVHG E\ VSLURFKHWH % EXUJGRUIHUL
• ,QFLGHQFH RI GLVHDVH LV VLJQLILFDQWO\ KLJKHU LI WLFN DWWDFKPHQW LV ORQJHU WKDQ 36-48 KRXUV
Subjective:
• 6LJQV DQG 6\PSWRPV
o ,OOQHVV KDV WKUHH VWDJHV
6WDJH IOX OLNH V\PSWRPV ZLWK W\SLFDO VNLQ UDVK HU\WKHPD PLJUDQV
6WDJH ZHHNV WR PRQWKV ODWHU SDWLHQWV GHYHORS PDODLVH IDWLJXH IHYHU
KHDGDFKH QHFN SDLQ DFKLQHVV PD\ GHYHORS FDUGLDF RU QHXURORJLF
PDQLIHVWDWLRQV
6WDJH PRQWKV WR \HDUV ODWHU WKH LOOQHVV FDQ PDQLIHVW LWVHOI DV
PXVFXORVNHOHWDO QHXURORJLF DQG VNLQ GLVHDVH XQOHVV LW LV WUHDWHG HDUO\
Objective:
• 3K\VLFDO ([DP
o (U\WKHPD mLJUDQV ³bXOO'V H\H UDVK´
&LUFXODU HU\WKHPDWRXV UDVK DW WKH VLWH RI WKH ELWH LQ RI SDWLHQWV ZLWK
PXOWLSOH OHVLRQV LQ
o )HYHU %HOO¶V SDOV\ FDUGLDF H[DP PD\ VKRZ GURSSHG EHDWV RU SHULFDUGLWLV
o /DWHU VWDJHV FDQ VKRZ MRLQW VZHOOLQJ DQG SDLQ FHUHEHOODU DWD[LD DQG QHXURORJLFDO
FKDQJHV
Assessment:
• 'LIIHUHQWLDO
o &HOOXOLWLV ORFDOL]HG LQIHFWLRQ ZLWKRXW QHXURORJLFDO PDQLIHVWDWLRQV
o $UWKURSRG ELWH 506)
o 3LW\ULDVLV URVHD SUHVHQFH RI D ³KHUDOG SDWFK´
o 5KHXPDWRLG DUWKULWLV QR H[SRVXUH WR WLFNV QR UDVK
Plan:
• 0HGLFDWLRQV
o 'R[\F\FOLQH RU DPR[LFLOOLQ
• 7KH GLDJQRVLV RI HDUO\ /\PH GLVHDVH LV FOLQLFDO
• (DUO\ WUHDWPHQW LV LPSRUWDQW WR SUHYHQW ODWH VHTXHODH
Patient Education:
• 3UHYHQWLRQ RI WLFN ELWHV LV LPSRUWDQW WUHDW FORWKHV DQG VNLQ
• )ROORZ XS $FWLRQV
o 5HWXUQ WR FOLQLF LQ KRXUV LI QR LPSURYHPHQW
Preceptor Directive:
• Blue Directive: Contact Preceptor Immediately
[ 373 ]
